Clinical Trials Logo

Clinical Trial Summary

This clinical trial will explore the safety and effect of GCSF-mobilized autologous ex vivo selected CD34 cells for the treatment of CMD in adults currently experiencing angina and with no obstructive coronary artery disease. Eligible subjects will receive a single intracoronary infusion of CLBS14.

Clinical Trial Description


Study Design

Related Conditions & MeSH terms

NCT number NCT03508609
Study type Interventional
Source Caladrius Biosciences, Inc.
Contact Chrissy Kotynski
Phone (908) 842-0093
Status Recruiting
Phase Phase 2
Start date April 19, 2018
Completion date April 2020

See also
  Status Clinical Trial Phase
Recruiting NCT02333591 - Effect of Intact GLP-1 (7-36) and GLP-1 Metabolite (9-36) on Coronary and Peripheral Vascular Function in Adults Phase 4
Completed NCT01014949 - Microcirculation Assessment in Diabetes and Metabolic Syndrome N/A